ICCS Organizers & Contact Information
|
Organizers from:
|
North America
|
|
Cambridge Innovation Partners is a consulting firm based in Cambridge, Massachusetts, that helps innovative startups find global and local resources for success. The firm offers emerging companies experienced and professional assistance to: develop and refine investment pitches; develop strategic business plans; identify most suitable launch markets; and to locate further sources of expertise (technical, legal, and managerial) able to provide effective, practical input. Cambridge Innovation Partners also supports the development of regional tech ecosystems to encourage, establish, and expand science- and tech-based companies.
In particular, Cambridge Innovation Partners has extensive expertise in a large range of programs which universities (and other research institutions) have developed to commercialize innovations and to support spin-off companies. www.cambridgeinternationalpartners.com Contact: Abigail Barrow, [email protected] |
|
Mass Medical Angels (MA2) is a seed stage investor group exclusively focused on life science and healthcare investments. Our mission is to bring more clinical tools to the marketplace, while attaining superior returns for our investors. To do this, we provide financing and mentoring to early-stage life-science companies so that they can obtain further funding, reach positive cash-flows or get acquired. MA2 members are carefully vetted for their deep expertise around the health sciences. Many of them have been researchers, clinicians, venture capitalists, executives, consultants, engineers, bankers or attorneys. They bring a willingness to support early stage companies to further our mission. In addition, we draw on our deep relationships with the institutions in Boston healthcare supercluster, the leading healthcare innovation center in the world. They provide additional resources, including deal flow, expertise and advisors for the companies we work with. www.massmedangels.com
|
|
Montréal InVivo, Québec, assumes a unifying leadership of all actors, whether they are organizations, institutions or companies working in this sector of Greater Montreal. We make sure to work with all stakeholders to strengthen the growth and competitiveness of the Life Science and Health Technology (LSHT) sector. We are known for our mobilizing force, our voice as a privileged independent interlocutor for the public sector as well as our ability to initiate and lead structuring projects for the development of the sector. Montréal InVivo is a credible source of information and the reference for the LSHT sector.
www.montreal-invivo.com Contact: Farah Bendahmane, [email protected] |
|
The Wistar Institute, Philadelphia, is the nation’s first independent institution devoted to medical research and training. The Wistar Institute has evolved from its beginnings as an anatomical teaching museum to its present-day status as an international leader in basic biomedical research.
In 1972, The Wistar Institute was designated a National Cancer Institute Cancer Center in basic research, a distinction it holds to this day. Wistar discoveries have led to the development of vaccines for rabies, rubella, and rotavirus, the identification of genes associated with breast, lung, and prostate cancer, and the development of monoclonal antibodies and other significant research technologies and tools. www.wistar.org Contact: Heather A. Steinman, [email protected] |
|
Organizers from:
|
Europe |
|
Oslo Cancer Cluster is an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatment. Organized as national non-profit member organization, the nearly 100 members represent the entire value chain including academic research institutes, university hospitals, start-ups, biotech and international Pharma companies. The cluster is advancing a growing pipeline of preclinical and clinical stage assets with strength in cancer immunotherapy and precision medicine. www.oslocancercluster.no
Contact: Jutta Heix, [email protected] |
|
OBN is the UK’s largest and most innovative not-for-profit R&D membership organisation for Life Sciences with over 400-member companies, ranging from start-ups through to unicorns and Big Pharma, and is the most national of all the UK membership groups.
Our goal is to create and develop an environment that nurtures the emergence and growth of innovative and successful Life Sciences companies and new products / services by providing unrivalled opportunities for networking, partnering, purchasing, training, advising and advocacy activities. OBN’s four distinct and differentiated flagship events (BioTrinity, BioForward BioSeed, & OBN Awards) are a series of major events where each satisfies a specific need but together address all the various & critical requirements of the life sciences sector. www.obn.org.uk Contact: John Harris, [email protected] |
|
Biopôle Lausanne is a life sciences campus hosting a vibrant community of world-renowned industry players and research institutes, based in Lausanne (Switzerland), at the heart of the Swiss Health Valley. It offers a world-class combination of modern infrastructure (up to 134,000 sqm/1,440,000 sqft of office and laboratory space), added value services, a dense network and unparalleled community engagement where members can thrive and bring science to life. Today, Biopôle houses more than 100 companies and organizations, 25 world-famous research groups, a life science incubator (StartLab) and a Digital Health Hub, enabling outstanding innovation for the betterment of healthcare. www.biopole.ch
Contact: Olivier Philippe, [email protected] |
|
Matwin is a French open-innovation platform strictly dedicated to the support of innovation in oncology. Our main goal is to select R&D innovative projects (headed by French or European academic teams or start-ups) with high transfer potential in oncology and to support them through an accelerator programme in the development and closing of early-stage partnerships (with industrial partners or investors). The programme is supported by an ongoing partnership with major international companies involved in oncology: Amgen, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Exact Sciences, GlaxoSmithKline, Janssen, Nanostring Technologies, Novartis, Pfizer, Pierre Fabre, Roche & Sanofi.
On top of our support to project leaders, MATWIN organises each year a European Partnering convention so called MEET2WIN fully dedicated to open innovation in oncology. Each year the convention brings together nearly 300 european participants (international companies, biotechs, start-ups, researchers, investors, TTO, etc.) and generates more than 1,000 B2B meetings to increase collaboration opportunities in the fight against cancer. www.matwin.fr Contact: Lucia Robert, [email protected] |